Norveška - norveščina - Statens legemiddelverk

aspen pharma trading limited - Østriol - vaginalkrem - 0.1 %

Norveška - norveščina - Statens legemiddelverk

aspen pharma trading limited - Østriol - tablett - 1 mg

Norveška - norveščina - Statens legemiddelverk

aspen pharma trading limited - Østriol - tablett - 2 mg

Norveška - norveščina - Statens legemiddelverk

aspen pharma trading limited - Østriol - vagitorie - 0.5 mg

Evropska unija - norveščina - EMA (European Medicines Agency)

plethora pharma solutions limited - lidokain, prilocaine - for tidlig utløsning - anestetika - senstend er angitt for behandling av primær prematur ejakulasjon hos voksne menn.

Evropska unija - norveščina - EMA (European Medicines Agency)

covis pharma europe b.v. - aclidinium bromide - lungesykdom, kronisk obstruktiv - legemidler for obstruktive sykdommer i luftveiene, - bretaris genuair er indikert som en vedlikeholdsbronkodilatorbehandling for å lindre symptomer hos voksne pasienter med kronisk obstruktiv lungesykdom (kol).

Norveška - norveščina - Statens legemiddelverk

esteve pharmaceuticals gmbh - isosorbidmononitrat - depottablett - 40 mg

Norveška - norveščina - Statens legemiddelverk

karo pharma as - doksylaminhydrogensuksinat - tablett, filmdrasjert - 12.5 mg

Norveška - norveščina - Statens legemiddelverk

karo pharma as - doksylaminhydrogensuksinat - tablett, filmdrasjert - 25 mg

Evropska unija - norveščina - EMA (European Medicines Agency)

midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - Øyemidler - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).